國立虎尾科技大學 |

ACEi and ARBS in hypertension and heart failure

Record Type:	Language materials, printed : Monograph/item
Title/Author:	ACEi and ARBS in hypertension and heart failure/ edited by Pasquale Perrone Filardi.
other author:	Perrone Filardi, Pasquale.
Published:	Cham :Springer International Publishing : : 2015.,
Description:	x, 150 p. :ill. (some col.), digital ; : 24 cm.;
Contained By:	Springer eBooks
Subject:	Angiotensin converting enzyme - Inhibitors. -
Online resource:	http://dx.doi.org/10.1007/978-3-319-09788-6
ISBN:	9783319097886 (electronic bk.)

ACEi and ARBS in hypertension and heart failure
ACEi and ARBS in hypertension and heart failure[electronic resource] /edited by Pasquale Perrone Filardi. - Cham :Springer International Publishing :2015. - x, 150 p. :ill. (some col.), digital ;24 cm. - Current cardiovascular therapy ;5. - Current cardiovascular therapy ;5..

Pathogenetic mechanisms of RAS involvement in cardiovascular diseases -- Antiotensin converting enzyme inhibitors and at1 antagonists for treatment of hypertension.-- Renin angiotensin system antagonism in heart failure -- Impact of co-morbidities on RAS inhibitors choice in hypertensive and heart failure patients -- Target organ damage and RAS blockade.

This book summarizes how the renin angiotensin system is implicated in the progression of atherosclerotic disease as well as of left ventricular dysfunction and reviews the action of angiotensin converting enzyme inhibitors and AT1 receptor antagonists on reducing morbidity and mortality in patients with left ventricular dysfunction or in those at high cardiovascular risk with preserved ventricular function. ACEi and ARBS in Hypertension and Heart Failure is a highly practical reference reviewing the evidence and providing a rationale for the appropriate use of RAS antagonists in cardiovascular diseases. It is written in an easy-to-follow format and with many illustrations to aid clarity and the assimilation of information. Each chapter is written by established authorities in their fields who are also experienced in explaining often complex concepts. The result is a unique book which is not only comprehensive but also clear and useful for the busy medical practitioner.

ISBN: 9783319097886 (electronic bk.)

Standard No.: 10.1007/978-3-319-09788-6doiSubjects--Topical Terms:

1063598
Angiotensin converting enzyme
--Inhibitors.

LC Class. No.: RC684.A53

Dewey Class. No.: 616.1206

ACEi and ARBS in hypertension and heart failure
LDR:02332nam a2200325 a 4500 001 834800
003 DE-He213
005 20150623090458.0
006 m d
007 cr nn 008maaau
008 160421s2015 gw s 0 eng d
020 $a 9783319097886 (electronic bk.)
020 $a 9783319097879 (paper)
024 7 $a 10.1007/978-3-319-09788-6 $2 doi
035 $a 978-3-319-09788-6
040 $a GP $c GP
041 0 $a eng
050 4 $a RC684.A53
072 7 $a MJD $2 bicssc
072 7 $a MED010000 $2 bisacsh
082 0 4 $a 616.1206 $2 23
090 $a RC684.A53 $b P459 2015
245 0 0 $a ACEi and ARBS in hypertension and heart failure $h [electronic resource] / $c edited by Pasquale Perrone Filardi.
260 $a Cham : $c 2015. $b Springer International Publishing : $b Imprint: Springer,
300 $a x, 150 p. : $b ill. (some col.), digital ; $c 24 cm.
490 1 $a Current cardiovascular therapy ; $v 5
505 0 $a Pathogenetic mechanisms of RAS involvement in cardiovascular diseases -- Antiotensin converting enzyme inhibitors and at1 antagonists for treatment of hypertension.-- Renin angiotensin system antagonism in heart failure -- Impact of co-morbidities on RAS inhibitors choice in hypertensive and heart failure patients -- Target organ damage and RAS blockade.
520 $a This book summarizes how the renin angiotensin system is implicated in the progression of atherosclerotic disease as well as of left ventricular dysfunction and reviews the action of angiotensin converting enzyme inhibitors and AT1 receptor antagonists on reducing morbidity and mortality in patients with left ventricular dysfunction or in those at high cardiovascular risk with preserved ventricular function. ACEi and ARBS in Hypertension and Heart Failure is a highly practical reference reviewing the evidence and providing a rationale for the appropriate use of RAS antagonists in cardiovascular diseases. It is written in an easy-to-follow format and with many illustrations to aid clarity and the assimilation of information. Each chapter is written by established authorities in their fields who are also experienced in explaining often complex concepts. The result is a unique book which is not only comprehensive but also clear and useful for the busy medical practitioner.
650 0 $a Angiotensin converting enzyme $x Inhibitors. $3 1063598
650 0 $a Hypertension $x Chemotherapy $3 1063599
650 0 $a Heart failure $x Chemotherapy. $3 1063600
650 1 4 $a Medicine & Public Health. $3 593949
650 2 4 $a Cardiology. $3 593957
650 2 4 $a Pharmacotherapy. $3 973587
700 1 $a Perrone Filardi, Pasquale. $3 1063596
710 2 $a SpringerLink (Online service) $3 593884
773 0 $t Springer eBooks
830 0 $a Current cardiovascular therapy ; $v 5. $3 1063597
856 4 0 $u http://dx.doi.org/10.1007/978-3-319-09788-6
950 $a Medicine (Springer-11650)